Q-omics provides the consensus-scored SNORD107 profile across patient tissues and cancer cell-line models. Additionally, SNORD107 mutation status shows 213 significant gene co-expression associations, with the highest sampling consensus in SKCM.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SNORD107 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SNORD107 in patient tissues and cancer cell lines. In patient samples, SNORD107 shows the broadest associations at the RNA and protein expression levels, with SKCM recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼Mutation
RNA	213	SKCM (196)	view →
▼RNA
Drug	1	PEMB_ALL (1)	view →